Cargando…
Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis
BACKGROUND: Schistosoma japonicum is a parasitic flatworm that is the aetiological agent of human schistosomiasis, an important cause of hepatic fibrosis. Schistosomiasis-induced hepatic fibrosis is a consequence of the highly fibrogenic nature of egg-induced granulomatous lesions, which are the mai...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088642/ https://www.ncbi.nlm.nih.gov/pubmed/33933138 http://dx.doi.org/10.1186/s13071-021-04734-1 |
_version_ | 1783686883674423296 |
---|---|
author | Huang, Jing Yin, Xinguang Zhang, Lifang Yao, Ming Wei, Dahai Wu, Yiming |
author_facet | Huang, Jing Yin, Xinguang Zhang, Lifang Yao, Ming Wei, Dahai Wu, Yiming |
author_sort | Huang, Jing |
collection | PubMed |
description | BACKGROUND: Schistosoma japonicum is a parasitic flatworm that is the aetiological agent of human schistosomiasis, an important cause of hepatic fibrosis. Schistosomiasis-induced hepatic fibrosis is a consequence of the highly fibrogenic nature of egg-induced granulomatous lesions, which are the main pathogenic features of schistosomiasis. Although global awareness of the association between schistosomiasis-induced hepatic fibrosis and S. japonicum infection is increasing, little is known about the molecular differences associated with rapid progression to schistosomiasis in cirrhotic patients. METHODS: We systematically used data-independent acquisition (DIA)-based liquid chromatography-mass spectrometry to identify differentially expressed proteins in serum samples from patients with advanced S. japonicum-induced hepatic fibrosis. RESULTS: Our analysis identified 1144 proteins, among which 66 were differentially expressed between the healthy control group and the group of patients with advanced S. japonicum-induced hepatic fibrosis stage F2 (SHF-F2) and 214 were differentially expressed between the SHF-F2 and SHF-F4 groups (up- or downregulation of at least 1.5-fold in serum samples). The results also indicated that two selected proteins (C1QA and CFD) are potential biomarkers for distinguishing between patients with SHF-F2 and those with SHF-F4 due to S. japonicum infection. CONCLUSIONS: We provide here the first global proteomic profile of serum samples from patients with advanced S. japonicum-induced hepatic fibrosis. The proteins C1QA and CFD are potential diagnostic markers for patients with SHF-F2 and SHF-F4 due to S. japonicum infection, although further large-scale studies are needed. Our DIA-based quantitative proteomic analysis revealed molecular differences among individuals at different stages of advanced S. japonicum-induced hepatic fibrosis and may provide fundamental information for further detailed investigations. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-021-04734-1. |
format | Online Article Text |
id | pubmed-8088642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80886422021-05-03 Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis Huang, Jing Yin, Xinguang Zhang, Lifang Yao, Ming Wei, Dahai Wu, Yiming Parasit Vectors Research BACKGROUND: Schistosoma japonicum is a parasitic flatworm that is the aetiological agent of human schistosomiasis, an important cause of hepatic fibrosis. Schistosomiasis-induced hepatic fibrosis is a consequence of the highly fibrogenic nature of egg-induced granulomatous lesions, which are the main pathogenic features of schistosomiasis. Although global awareness of the association between schistosomiasis-induced hepatic fibrosis and S. japonicum infection is increasing, little is known about the molecular differences associated with rapid progression to schistosomiasis in cirrhotic patients. METHODS: We systematically used data-independent acquisition (DIA)-based liquid chromatography-mass spectrometry to identify differentially expressed proteins in serum samples from patients with advanced S. japonicum-induced hepatic fibrosis. RESULTS: Our analysis identified 1144 proteins, among which 66 were differentially expressed between the healthy control group and the group of patients with advanced S. japonicum-induced hepatic fibrosis stage F2 (SHF-F2) and 214 were differentially expressed between the SHF-F2 and SHF-F4 groups (up- or downregulation of at least 1.5-fold in serum samples). The results also indicated that two selected proteins (C1QA and CFD) are potential biomarkers for distinguishing between patients with SHF-F2 and those with SHF-F4 due to S. japonicum infection. CONCLUSIONS: We provide here the first global proteomic profile of serum samples from patients with advanced S. japonicum-induced hepatic fibrosis. The proteins C1QA and CFD are potential diagnostic markers for patients with SHF-F2 and SHF-F4 due to S. japonicum infection, although further large-scale studies are needed. Our DIA-based quantitative proteomic analysis revealed molecular differences among individuals at different stages of advanced S. japonicum-induced hepatic fibrosis and may provide fundamental information for further detailed investigations. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-021-04734-1. BioMed Central 2021-05-01 /pmc/articles/PMC8088642/ /pubmed/33933138 http://dx.doi.org/10.1186/s13071-021-04734-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Huang, Jing Yin, Xinguang Zhang, Lifang Yao, Ming Wei, Dahai Wu, Yiming Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title | Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title_full | Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title_fullStr | Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title_full_unstemmed | Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title_short | Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis |
title_sort | serum proteomic profiling in patients with advanced schistosoma japonicum-induced hepatic fibrosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088642/ https://www.ncbi.nlm.nih.gov/pubmed/33933138 http://dx.doi.org/10.1186/s13071-021-04734-1 |
work_keys_str_mv | AT huangjing serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis AT yinxinguang serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis AT zhanglifang serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis AT yaoming serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis AT weidahai serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis AT wuyiming serumproteomicprofilinginpatientswithadvancedschistosomajaponicuminducedhepaticfibrosis |